Roselene Mesquita Augusto Passos | Hematology | Best Researcher Award

Published on by Global Academic Awards

Dr. Roselene Mesquita Augusto Passos | Hematology | Best Researcher Award

Dr. Roselene Mesquita Augusto Passos, Universidade de São Paulo, Brazil

Dr. Roselene Mesquita Augusto Passos is a physician specializing in Pediatrics, Pediatric Hematology, and Bone Marrow Transplantation. She graduated in Medicine from UNISA (1993), completed her medical residency at USP, and completed additional training in oncohematology in the USA. She is currently the technical manager of the BMT service at Hospital Brigadeiro, a physician at Hospital 9 de Julho and Hospital Alemão Oswaldo Cruz, and a PhD student at FMUSP, studying the cost-effectiveness of plerixafor. She also works at the Cancer Center in São Paulo. She is the author of relevant publications in the area, focusing on BMT complications, pediatric sedation, and hematologic diseases.

Publication Profile

Orcid

Academic Background

Dr. Roselene Passos is a dedicated physician specializing in pediatric hematology. She earned her medical degree from the University of Santo Amaro (UNISA) in 1993 🎓 and completed a medical residency in pediatrics at the University of São Paulo (USP) between 1994 and 1996 🏥. She further specialized in pediatric hematology (1996–1998) under Dr. Vicente Odoni Filho and later trained in oncohematology at DeVos Children Hospital in the U.S. in 2005 🇺🇸. Currently, she is pursuing a PhD at HCFMUSP, focusing on the cost-effectiveness of plerixafor in stem cell mobilization for autologous transplantation 💉📊.

Professional Performance

Since 1997, Dr. Roselene Passos has served as a dedicated public servant with exclusive dedication, currently acting as the Technical Manager of the Bone Marrow Transplant (BMT) Unit at Brigadeiro Hospital ⚕️. She worked in the pediatric hematology unit from 1997 to 2009 and has been a physician in the hospital’s BMT Unit since June 2007 🧫. In April 2016, she assumed the role of Technical Manager of the BMT unit. Additionally, since 2020, she has been affiliated as a registered physician with an 8-hour weekly commitment in the same unit, contributing her expertise to hematologic care and transplantation 🌟.

Areas of activity

Dr. Roselene Passos specializes in key areas of Health Sciences, with a strong focus on pediatric hematology and bone marrow transplantation. Her primary field is Medicine, specifically within the subarea of Pediatric Hematology, where she provides expert care to children with blood disorders 👩‍⚕️🧒. She also holds specialization in Hematology, contributing to the diagnosis and treatment of complex hematologic conditions 🧪. Additionally, Dr. Passos is deeply engaged in the field of Bone Marrow Transplantation, playing a vital role in stem cell mobilization and transplant procedures for pediatric patients in need of advanced therapeutic care 🌱🧫

Awards and Professional Titles 🏅🩺📜

Dr. Roselene Mesquita Augusto Passos has earned notable professional titles that underscore her expertise in pediatric and hematologic care. In 2010, she was awarded the Specialist Title in Hematology and Hemotherapy by the Brazilian Association of Hematology and Hemotherapy, recognizing her advanced knowledge and contributions in blood disorders and treatment 💉🩸. Earlier, in 1996, she received the Specialist Title in Pediatrics from the Brazilian Society of Pediatrics, affirming her commitment to pediatric healthcare and child well-being 👶🩺. These distinctions highlight her dedication and excellence across both pediatric and hematologic disciplines. 🌟

Research Focus

Dr. Roselene Mesquita Augusto Passos specializes in hematology with a focus on the economic and clinical aspects of hematopoietic stem cell mobilization and leukapheresis for autologous transplantation. Her research primarily addresses the cost-effectiveness of using plerixafor in patients with multiple myeloma and lymphoma, particularly in comparison to preemptive versus rescue strategies. She is also involved in evaluating pharmacoeconomics in hematology treatments. Through systematic reviews, Dr. Passos contributes significantly to improving treatment protocols and optimizing healthcare resources in hematology.

Conclusion

Dr. Passos is a strong candidate for the Best Researcher Award due to her sustained clinical research, leadership in pediatric hematology, and active involvement in cutting-edge stem cell therapy research.

Publication Top Notes

  • Cost‐Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma
  • Economic evaluation of plerixafor addition in the mobilization and leukapheresis of hematopoietic stem cells for autologous transplantation: a systematic review